Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019


Phacilitate Leaders Europe Agenda


Closing Panel Discussion: Developing robust processes as we scale up is the single biggest challenge facing advanced therapies today - how can the industry address this?

18 Sep 2019
Manufacturing & Commercialisation
Stephen Sullivan, International Liaison Officer - GAiT
Katy Newton, VP Process Development - Achilles Therapeutics
Lindsey Clarke, Cell Therapy Product Manager - Bio-Techne
Paul Lloyd-Evans, Head of Clinical Biotechnology Centre - NHS
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd